Publicación:
High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis

Vista sencilla de ítem
dc.contributor.authorMarsden, P.D.
dc.contributor.authorSampaio, R.N.R.
dc.contributor.authorCarvalho, E.M.
dc.contributor.authorVeiga, J.P.
dc.contributor.authorCosta, J.L.
dc.contributor.authorLlanos-Cuentas, E.A.
dc.date.accessioned2026-05-14T14:28:18Z
dc.date.issued1985
dc.description.abstractThe treatment of two patients with severe mucosal leishmaniasis due to Leishmania braziliensis braziliensis is described. Both patients had received much prior antimonial therapy and one had relapsed after a total dose of 2.5 g of Amphotericin B. Both patients responded to prolonged continuous Pentostam therapy at a daily dose of 20 mg Sb(v)/kg/day for 62 days in one case and for 85 days in the other. Pentavalent antimonials can be curative in such protracted courses in selected patients unresponsive to standard chemotherapy.en_US
dc.identifier.doihttps://doi.org/10.4269/ajtmh.1985.34.710
dc.identifier.scopus2-s2.0-0022385127
dc.identifier.urihttps://hdl.handle.net/20.500.12866/19668
dc.language.isoeng
dc.relation.ispartofurn:issn:0002-9637
dc.relation.ispartofseriesAmerican Journal of Tropical Medicine and Hygiene
dc.relation.issn0002-9637
dc.rightshttp://purl.org/coar/access_right/c_14cb
dc.titleHigh continuous antimony therapy in two patients with unresponsive mucosal leishmaniasisen_US
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.type.localArtículo de revista
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication

Archivos

Colecciones

Artículos Científicos no Financiados
Referencias bibliográficas